Virtual Medicinal Product (VMP) - Medroxyprogesterone 500mg/2.5ml suspension for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Medroxyprogesterone 500mg/2.5ml suspension for injection vials Start Date 04-06-2004 End Date
Previous Name Previous Name Medroxyprogesterone 200mg/ml injection 2.5ml vials Start Date 02-12-2002 End Date 03-06-2004
Abbreviated Name Abbreviated Name Medroxyprogesterone 500mg/2.5ml inj vials Start Date 01-05-2009
Previous Abbreviated Name Medroxyprogesterone 500mg/2.5ml susp for inj vials Previous Start Date 10-09-2004 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
2.5
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Suspension for injection
Ontology Form/Route
suspensioninjection.intramuscular
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L02AB02
BNF Start Date End Date
Current BNF 08030200 Start Date 04-04-2022 End Date
Previous BNF 08030200 Start Date 14-02-2005 End Date 21-11-2007
Previous BNF 07030202 Start Date 14-02-2005 End Date 21-11-2007
SNOMED Codes
Code Start Date End Date
36041611000001107 29-10-2018
327279000 02-12-2002 28-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Medroxyprogesterone acetate Based on Ingredient Substance 200 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial